|
Table 2: Drugs associated with high triglycerides levels. |
|
|
Hormonal |
• Oral oestrogens (40%) |
|
• Selective estrogen receptor modulators (20%) |
|
|
• Steroids |
|
|
• Tamoxifen (20%) |
|
|
• Raloxifen (20%) |
|
|
• Clomiphene (40%) |
|
|
• Growth hormone therapy |
|
|
• Androgen deprivation therapy (15%) |
|
|
Cardiometabolics |
• Non cardioselective beta blockers (20%) |
|
• Thiazides (15%) |
|
|
• Diuretics (10%) |
|
|
• Bile acid sequestrants |
|
|
Immunosuppressants |
• Cyclosporine (20%) |
|
• Sirolimus (30%) |
|
|
• Tacrolimus (30%) |
|
|
• Interferon alpha (20%) |
|
|
Anti-cancer therapeutics |
• L-asparaginase |
|
• Cyclophosphamide |
|
|
• Tyrosin-kinase inhibitors (20-70%) |
|
|
Others |
• Retinoids (40%) |
|
• Protease inhibitors (100%), ITRN (50%), ITRNN (40%), INH, INTEG (0%) |
|
|
• Antidepressants y atypical antipsychotics (30%) |
|
|
• Propofol (20%) |
|